Hypothermic oxygenated machine perfusion for extended criteria donor allografts: Preliminary experience with extended organ preservation times in the setting of organ reallocation

Background In times of critical organ shortage, poor organ pool utilization and increased use of extended‐criteria donor (ECD) allografts remain a major problem. Hypothermic oxygenated machine perfusion (HOPE) has emerged as a promising and feasible strategy in ECD liver transplantation (LT). Howeve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Artificial organs 2022-02, Vol.46 (2), p.306-311
Hauptverfasser: Pavicevic, Sandra, Uluk, Deniz, Reichelt, Sophie, Fikatas, Panagiotis, Globke, Brigitta, Raschzok, Nathanael, Schmelzle, Moritz, Öllinger, Robert, Schöning, Wenzel, Eurich, Dennis, Pratschke, Johann, Lurje, Georg
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background In times of critical organ shortage, poor organ pool utilization and increased use of extended‐criteria donor (ECD) allografts remain a major problem. Hypothermic oxygenated machine perfusion (HOPE) has emerged as a promising and feasible strategy in ECD liver transplantation (LT). However, potential safety limits regarding the duration of perfusion are yet to be explored. Besides marginal allograft quality (steatosis), prolonged cold ischemia time remains the most important factor for a high number of liver allografts being declined for transplantation. Patients and Methods Two ECD‐allografts were each allocated to two recipients, who proved to be unsuitable to receive the assigned allograft upon arrival at the transplant center. The organs were reallocated by Eurotransplant and accepted by our center for two different backup patients. During that time, HOPE was commenced and continued until the recipient hepatectomy was completed. Postoperative allograft function was assessed by serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, and International Normalized Ratio. Incidence of early allograft dysfunction (EAD), postoperative complications, and length of hospital stay were analyzed. Results HOPE was applied for 4 h 35 min and 4 h 20 min, resulting in a total cold preservation time of 17 h 29 min and 15 h 20 min, respectively. Both recipients displayed decreasing serum transaminases and bilirubin levels postoperatively. No EAD or major postoperative complications occurred in either patient. Serum ALT and AST levels were within the normal range at discharge. Conclusions Extended HOPE enables the safe extension of preservation time for up to 18 h in human LT. End‐ischemic HOPE may significantly improve organ pool utilization, while simultaneously facilitating operating room logistics and preventing organ injury. Despite severe organ shortage, a relevant number of allografts is being declined because of marginal quality and prolonged cold ischemia time. Due to organ reallocation and operating room logistics, two extended‐criteria donor allografts were subjected to hypothermic oxygenated machine perfusion (HOPE), resulting in total cold preservation time of up to 18 h. No major complications or early allograft dysfunction occurred in either allograft. Extended HOPE might significantly improve organ pool utilization and facilitate operating room logistics.
ISSN:0160-564X
1525-1594
DOI:10.1111/aor.14103